Management of an outbreak of botulism with benign clinical presentation

Berkowitz AL. Tetanus, Botulism, and Diphtheria. Continuum (Minneap Minn) 24(5, Neuroinfectious Disease):1459–88. 10.1212/CON.0000000000000651. Rao AK, Lin NH, Griese SE, Chatham-Stephens K, Badell ML, Sobel J. Clinical criteria to trigger suspicion for botulism: an evidence-based tool to facilitate timely recognition of suspected cases during sporadic events and outbreaks. Clin Infect Dis 2017;66(suppl_1):S38. 10.1093/cid/cix814. Witoonpanich, 2009, Electrodiagnosis of botulism and clinico-electrophysiological correlation, Clin Neurophysiol, 120, 1135, 10.1016/j.clinph.2009.01.019 Tacket, 1984, Equine antitoxin use and other factors that predict outcome in type A food-borne botulism, Am J Med, 76, 794, 10.1016/0002-9343(84)90988-4 O'Horo JC, Harper EP, El Rafei A, Ali R, DeSimone DC, Sakusic A et al. Efficacy of antitoxin therapy in treating patients with foodborne botulism: a systematic review and meta-analysis of cases, 1923–2016. Clin Infect Dis 2017;66(suppl_1):S43–S56. 10.1093/cid/cix815. Fagan, 2009, Persistence of botulinum toxin in patients' serum: Alaska, 1959–2007, J Infect Dis., 199, 1029, 10.1086/597310 Sobel J, Malavet M, John S. Outbreak of clinically mild botulism type E illness from home-salted fish in patients presenting with predominantly gastrointestinal symptoms. Clin Infect Di. 2007 15;45(2):e14–6. 10.1086/597310.